Answers are grounded in this paper and cite their sources.
Objective: This study focused on the formulation of freeze dried Mangifera indica. (MI) lozenges dosage form, which enables proper dosing of MI for patients that are unable to swallow solid drugs. Methods: Soft lozenges containing freeze dried aqueous extract of MI were prepared by melting Polyethylene glycol 1000(PEG 1000) to 70o C and gradually addition of MI with stirring after cooling. The mixture was poured into a lozenges mould. MI combinations with standard diabetic drugs namely Glibenclamide and Metformin lozenges were also prepared. Evaluation of lozenges including weight uniformity test, specific gravity test, dissolution rate test, in-vitro release test and physical stability tests were carried out. Investigation on anti-diabetic effect of lozenges containing MI individual and combinations with standard drugs on streptozotocin induced diabetic rats were carried out. The fasting blood sugar and change in weight of diabetic rats at the end of 14 days treatment were determined. Results: All the lozenges passed weight uniformity test. Drug release profile showed that 100% MI was released after 1 min. The maximum anti-diabetic dose for MI lozenges was 250 mg/kg. The antidiabetic effect of MI lozenges was 65.03±12.09 %. The anti-diabetic activity of individual MI lozenge was the same with the Glibenclamide (65.30±14.33). Weight gained by MI lozenges treatment group was significantly higher (p<0.05) than Glibenclamide standard group. Conclusion: Lozenges containing MI freeze dried aqueous extract passed all parameters evaluated. The MI lozenges demonstrated significant anti-diabetic effect. MI combined with standard had no advantage over individual lozenges.
No takes yet. Share an insight, caveat, or question.
Dorathy et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: